Migraine headaches can be triggered or caused by a number of factors, but one of the most prevalent is a person's genetics.
Some San Francisco entrepreneurs have taken this insight and built a new startup around it. Their company, Mable, is offering a telehealth service specifically targeted at helping the up to 60% of migraine sufferers whose ailment is due to their genes.
"Most migraine treatment plans today fail to consider the crucial role of genetics," Roman Rothaermel, Mable's co-founder and CEO, said in a blog post. "We concluded that individualized, DNA-guided care was the smart approach to a powerful new alternative for the underserved migraine community."
Legally known as Neurolytic Healthcare Inc., Mable currently has a waiting list of more than 5,000 users that it's gradually introducing to its service. The startup, which has a patent pending on its services, according to Rothaermel, plans to offer its treatments to customers across 41 states by the end of this year. It charges customers both on a per-interaction and monthly subscription basis.
Mable has some new funds to help with its planned expansion. The startup announced last week it's raised $3.2 million in a combination of seed and pre-seed funding.
Here's more on Mable's deal and other seed funding news from this past week:
Resourcely Inc., San Jose, $8 million: Andreessen Horowitz and Felicis Ventures invested in this provider of secure cloud development tools.
MakersHub Inc., San Francisco, $4.5 million: TTV Capital led the round for this provider of an online marketplace service where manufacturers can place orders and request quotes from suppliers, according to Axios.
Mulberri Inc., Sunnyvale, $4 million: Hanover Technology Management, MS&AD Ventures and Altamont Capital Partners invested in this provider of an insurance marketplace for businesses.
Debt DAO, San Francisco, $3.5 million: Dragonfly Capital led the round for this provider of debt financing for blockchain-based decentralized autonomous organizations (DAOs). GSR, Numeus and Fasanara Capital also invested.
Neurolytic Healthcare Inc. (dba Mable), San Francisco, $3.2 million: Y Combinator and Illumina led the round for this telehealth company that focuses on migraine treatments. First In Ventures, Arkitekt Ventures and Inaki Berenguer also invested.
B9 Inc., San Francisco, $2.6 million: Sky Light Invest led the round for this financial service provider that offers payroll advances for what it calls "the underbanked." Finlink Inc. also invested.
Docsi18n Inc. (dba Coinfeeds), San Francisco, $2 million: FTX Ventures, Coinbase Ventures, Protocol Labs, Huobi Ventures and Y Combinator invested in this provider of a service that offers news, data and analysis for cryptocurrency investors.
